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Tanja Rezzonico Jost, Michele Proietti, and Fabio Grassi
Abstract— A novel system for remote monitoring of metabolism
in an animal model is proposed in this paper. The system
is obtained by integrating bio-nano-sensors to detect single-
metabolites, an electrochemical front-end made with off-the-shelf
components, a radio frequency communication sub-system, and
an antenna of new design. The system has been calibrated and
tested for continuous monitoring of four different metabolites:
glucose, lactate, glutamate, and adenosine triphosphate. Tests
using animal models (mice) have been conducted to investigate
tissue inflammation induced by the implanted bio-nano-sensors.
These tests confirm that our system is suitable and reliable
for remote monitoring of single-metabolites in experiments with
animal models.
Index Terms— Animal monitoring, body sensor node, carbon
nanotubes, implantable, SYST.
I. INTRODUCTION
GENETICALLY engineered mice are highly useful mod-els for emulating human diseases and studying disease
mechanisms as well as for testing therapeutic strategies [1].
Remote monitoring during the experiments assures continuous
acquisition of data on soluble mediators in animal model.
Remote monitoring of blood pressure in mice has been already
demonstrated including remote powering of the system [2].
Although many other physiological parameters, e.g. the vis-
cosity [3], may be monitored by telemetry, the big challenge is
the monitoring of the animal model at molecular level. Thus, it
is so important to follow in time the biomarkers trend related
to the disease under investigation. Continuous monitoring of
humans is already in the market for glucose [4] as well as for
lactate. The reliability of the technology for glucose remote
monitoring has been validated up to 8 month in mice [5], [6]
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Fig. 1. System for remote acquisitions with single-metabolite bio-nano-
sensors.
and up to one year in pigs [7]. The next step will be the
extension of the technology to other relevant metabolites like,
for example, glutamate and ATP. Glutamate is an important
neurotransmitter usually associated with brain damages [8]
while ATP has been very recently associated to regulation
of adaptive immune responses [9]. Several nano-materials
have been proposed to improve devices performance including
conductive polymers [10], nano-particles [11], graphene [12],
and carbon nanotubes [13]. Recently, carbon nanotubes have
been demonstrated to enhance the sensitivity for both exoge-
nous [14] and endogenous [15] metabolites. The aim of the
present paper is to propose the first telemetry system based on
Bio-Nano-Sensors and reliable for remote and continuous
single-metabolite monitoring of glucose, lactate, glutamate,
and ATP in mouse models.
II. REMOTE MONITORING SYSTEM
A. Wireless Implantable System
A wireless electrochemical monitoring system has been
realized to assess the sensor in-vivo, as shown in Fig.1.
This embedded system responds to the constraints linked to
implants in animals. The materials used to build the packaging
are biocompatible and support chemical sterilization process
such as ethylene oxide gas or chlorine bleach. The wireless
link allows us to perform measurements at distance with a
laptop computer that can be easily brought into the operation
room.
B. Implantable Body Sensor Node
The telemetry system is based on an implantable Body Sen-
sor Node (BSN) for rheology monitoring, which architecture
has been already described in [3], [16], [17].
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C. Electrochemical Front-End
The novelty proposed in this paper for the remote moni-
toring system is in the electrochemical frontend. VLSI design
provides fully customized solutions for also addressing multi
channels chip [18] with detection of femptoampere cur-
rents [19], even including differential configurations [20].
However, the system proposed here does not require complex
architectures. Therefore, our frontend to interface the BSN
to the electrochemical Nano-Bio-Sensor was realized with a
simple potentiostat following [21]. It is based on the com-
mercial IC MAX4039 (manufactured by Maxim integrated
products – biggest IC in the board of Fig. 1) that integrates two
operational amplifiers and one voltage reference (1.2 V). The
IC is powered by the 3 V battery and consumes only 9 µW.
The potentiostat is mounted on a circular Printed Circuit Board
(PCB) of 7 mm in diameter (photo on the right of Fig. 1),
which is placed at the end of the BSN, just after the batteries.
The potentiostat output is connected to the DSP analogue-to-
digital converter (smallest IC in the board of Fig. 1). Then
the signal is low-pass filtered and the data are directly sent
to the base station. A computer connected to the base station
can display the data in real-time and save them for further
analysis.
The computer can also set the measurement by remotely
enabling and disabling the BSN. With the embedded non-
rechargeable batteries exhibiting a total energy of 600 J,
the system can be powered in stand-by for over 9 years.
Then, the Bio-Nano-Sensor (see Section III) is connected to a
biocompatible cable in polyurethane with silver coated wires
that goes through the BSN housing to the potentiostat.
III. SINGLE-METABOLITE BIO-NANO-SENSORS
A. Chemicals
Multi-Walled Carbon Nanotubes (MWCNT) were pur-
chased in powder (90% purity) from Dropsens (Spain). Glu-
cose oxidase from Aspergillus Niger (GOD, EC 1.1.3.4,
129.9 units/mg solid) lactate oxidase from Pediococcus species
(LOD, EC 1.13.12.4, ≥20 units/mg solid), hexokinase (HEX)
type 3 from Baker Yeast, D-(+)-glucose, lithium L-lactate,
and L-glutamic acid were purchased from Sigma-Aldrich
(Switzerland) as lyophilized powder. Glutamate oxidase from
Streptomyces species (GlOD, EC 1.4.3.11, 25 units) was
supplied from Yamasa Co. (Japan). All the proteins were
dissolved in Phosphate Buffer Solution (PBS) 0.01 M at pH
7.4, while the other reagents were dissolved in Milli-Q.
B. Screen-Printed Electrodes
Experiments were carried out using screen-printed elec-
trodes (SPE) from Dropsens (Spain). Working and counter
electrodes are made of graphite, while the reference electrode
is in Ag/AgCl. The total area of the cell is around 22 mm2,
with a working electrode of 4 mm in diameter.
C. Preparation of the Bio-Nano-Sensors
A 40 µl volume of the MWCNT-chloroform solution was
deposited by drop casting (5 µl each time) onto the working
Fig. 2. Calibration curve for Glucose detection in 0 to 2 mM concentration
range.
electrode and dried. Then, 20 µl of the enzyme probe were
dropped onto the working electrode and stored overnight at
+ 4 ºC, in order to allow the adsorption of the proteins
onto the electrode surface. Glucose and lactate oxidases were
prepared at concentrations of 15 mg/ml, and of 125 mg/ml,
respectively [22], [23]. The glutamate oxidase was prepared at
the concentration of 250 units/ml. For the measure of the ATP,
instead, GOD and HEX were mixed in a 1:1 ratio to obtain a
solution at pH 7.4 with 15 mg/ml of each protein [24]. 20 µl
of the solution were then drop cast onto the working electrode,
and let dry at 4 ºC overnight. The electrodes were rinsed out
with Milli-Q the day after the deposition and conditioned for
10 minutes at constant potential (+ 650 mV) before the first
use.
D. Calibration Curves and Telemetry Acquisitions
For calibration and investigation of the detection limit, elec-
trodes were dipped into the PBS with a volume of 25 ml under
stirring conditions. The electrochemical response of elec-
trodes is investigated by chronoamperometries under aerobic
conditions. The Bio-Nano-Sensors calibration has been done
with the lab-electrochemical-station Versastat 3 potentiostat
(Princeton Applied Technologies). After calibration, the same
Bio-Nano-Sensors have been used for remote acquisitions in
order to test the telemetry system described in the previous
section.
IV. IN-VITRO AND IN-VIVO TESTS
A. Calibration for Glucose, Lactate, and Glutamate
Oxidases are enzymes that catalyze the transformation of
metabolite (X) in metabolism product (X p) by following the
well-known equation:
X + O2 X O D−→ X P + H2O2. (1)
The metabolite X is glucose, lactate, and glutamate, which are
catalyzed by the glucose-oxidase (GOD), the lactate-oxidase
(LOD), and the glutamate-oxidase (GLOD), respectively.
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Fig. 3. Calibration curve for Lactate detection in the 0 to 1.4 mM
concentration range.
Fig. 4. Calibration curve for Glutamate detection in 0 to 2 mM concentration
range.
The reaction (1) produces the hydrogen peroxide (H2O2) that
may be oxidized:
2H2O2
+650mV−→ O+2 + 2H2O + 4e− (2)
or reduced:
H2O2 + 2H + + 2e− +1540 mV−→ 2H2O (3)
at the interface with our electrodes. Equations (2) and (3) are
two different redox reactions, the first enabled at the electrodes
interface with a typical potential of + 650 mV, while the
second with typical potential of + 1540 mV.
Of course, these potentials also depend on the metal
of the electrodes. In presence of oxygen, reaction (2) is
the most common used. So, for our Bio-Nano-Sensors we
worked at +650 mV by following the redox of equation (2).
Figs. 2–4 report the calibration curves for three different
metabolites. The obtained sensitivities and the ranges of con-
centration are reported in Table I.
B. Calibration for ATP
In the case of the ATP monitoring, our Bio-Nano-Sensor
consists of two co-immobilized enzymes: glucose oxidase and
Fig. 5. Calibration curve for ATP detection in the 0 to 1.4 mM concentration
range.
TABLE I
SENSITIVITY AND RANGE OF THE BIO-NANO-SENSORS
Metabolite Sensitivity Range
Glucose 299 nA/µM mm2 0.5–4 mM
Lactate 446 nA/µM mm2 0.5–2.5 mM
Glutamate 40 nA/µM mm2 0.5–2 mM
ATP 34 pA/µM mm2 200–1400 µM
hexokinase. Both enzymes are sensitive to glucose, but with a
different catalytic mechanism [24]:
D − Glucose + O2 G O D−→ D − Gluconic Acid
+ H2O2. (4)
D − Glucose + AT P H E X−→ D − Glucose − 6 − P
+ ADP. (5)
In presence of ATP, the hexokinase competes with the glucose
oxidase for the substrate, and the quantity of hydrogen per-
oxide produced in the reaction (4) is proportionally decreased
by the glucose consumption in the reaction (5). Therefore, the
ATP is detected by a decreasing of the current registered in the
redox reaction (2). Fig. 5 reports the obtained calibration curve
for the ATP detection The obtained sensitivity is reported in
in table I, too.
C. Telemetry Acquisitions
The metabolite is kept by the enzymes, transformed, and
then released in all the reactions involving oxidases and
hexokinase. This feature of reactions (1), (4), and (5) enables
continuous monitoring and acquisition over time of current
variation as proportionally related to the concentration of the
monitored metabolites. Fig. 6 shows the continuous monitoring
of glucose over a time frame of 35 minutes, while Fig. 7 shows
the continuous monitoring over a time frame of 16 minutes
in the case of Lactate. Similarly, continuous monitoring of
glutamate and ATP is acquired, as shown in Figs. 8 and 9.
Figs. 8 and 9 clearly show that raw signals acquired on
each single Bio-Nano-Sensor are typically very noisy. Noise
rejection is done by averaging on 20 data points and moving
this average along the entire data stream. Figs. 6 and 7 show
signals after such filtering.
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Fig. 6. Continuous monitoring with the single-metabolite remote system and
a glucose bio-nano-sensor.
Fig. 7. Continuous monitoring with the single-metabolite remote system and
a lactate bio-nano-sensor.
Fig. 8. Continuous monitoring with a glutamate bio-nano-sensor.
D. Tests With Animal Models
To check whether the Nano-Bio-Sensor has any influence
on tissue homeostasis at the site of implantation, we moni-
tored inflammatory reaction in vivo in air pouches in mice
(see Fig. 10) in which the Nano-Bio-Sensors were implanted.
The air pouch is generated by subcutaneous injection of sterile
air into the back of a mouse. The resulting subcutaneous cavity
has a diameter of around 1.5 cm and a height of 0.5 cm.
Fig. 9. Continuous monitoring with an ATP bio-nano-sensor.
Fig. 10. Air pouch model in mice used in this paper to test the inflammatory
behavior of the monitoring implants.
Fig. 11. Tests of inflammation in the mouse induced by the implanted bio-
nano-sensor and the wear remote system.
The air pouch does not induce any relevant reaction of the
tissue and provides an environment in which studying local-
ized inflammatory phenomena by different stimuli, including
the introduction of a Bio-Nano-Sensor. To study the impact of
the implant, we inserted the sensor into the air pouch and
analyzed the ATP concentration and neutrophils infiltration
at day 7 after implantation. ATP is the source of energy
for the cell. It is present at high concentration inside cells
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but virtually absent in extracellular fluids. Cell damage, such
as the one taking place at inflammatory sites, determines
the efflux of ATP from the cells and its appearance in the
extracellular fluid, making it a so-called danger-associated
molecular pattern. Neutrophils constitute around 50–70% of
our circulating white blood cells and extravasate from blood
vessels at inflammatory sites. Therefore, their presence and
number is an important parameter to score inflammatory
reactions. We analyzed these two parameters of inflammation
in different experimental conditions. The ATP concentration in
the subcutaneous microenvironment is not affected by suture.
Some increase in neutrophils infiltration is detected by more
invasive procedures such as performing the hole for implanting
the biochip or the implantation of our Nano-Bio-Sensors.
ATP levels and neutrophils increased to a similar extent
by LPS (bacterial lipopolysaccharide) injection, confirming
the limited inflammation associated with sensor implantation
(Fig. 11). Nevertheless, the level of ATP induced by the
implant (from 20 to 60 nM depending on different implanted
sensors) is largely below the targeted range of hundreds of
µM for ATP concentrations found in cell signaling [9] and
relevant for anticancer treatments [25].
V. CONCLUSION
A novel system for remote monitoring of metabolism at
molecular level in translational research made with animal
models has been proposed in the paper. The new proposed sys-
tem integrates Bio-Nano-Sensors with electrochemical front-
end for the detection, a proper transceiver, battery for the
powering, and a novel antenna. The Bio-Nano-Sensors are
suitable for continuous monitoring of glucose, lactate, gluta-
mate, and ATP (four highly relevant molecules of the human
metabolism). Good sensitivities were provided by carbon
nanotubes used as enhancers of the electrons transfer between
the probe proteins and the sensors electrode.
The electrochemical front-end has been built by using out-
of-the-shelf components. The low-power transceiver and the
antenna were especially designed for prolongation of the
implantation. The tests for continuous monitoring, wireless
communications, and biocompatibility demonstrated the feasi-
bility of this technology for translational research in biomed-
ical field with mouse models. Our in-vivo tests demonstrated
mild pro-inflammatory potential at implantation site, enabling
the exploitation of the proposed system for in-vivo monitoring.
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